Literature DB >> 30535950

Adenosine plasma level in patients with paroxysmal or persistent atrial fibrillation and normal heart during ablation procedure and/or cardioversion.

Baptiste Maille1,2, Marion Marlinge2,3, Donato Vairo4, Giovanna Mottola2,3, Linda Koutbi1, Pierre Deharo2, Marguerite Gastaldi2,3, Marine Gaudry5, Claire Guiol2, Sara Bottone6, Patrick Mace3, Rosita Gueant7, Mohamed Chefrour3, Elsa Martinez1, Pierre Michelet2,8, Jean Louis Gueant7, Alain Boussuges2, Jean Ruf2, Emmanuel Fenouillet2, Jean Claude Deharo1,2, Régis Guieu2,3, Frederic Franceschi1,2.   

Abstract

The mechanism of atrial fibrillation (AF) in patients with normal heart remains unclear. While exogenous adenosine can trigger AF, nothing is known about the behavior of endogenous adenosine plasma level (APL) at the onset of AF and during ablation procedure. Ninety-one patients (68 with paroxysmal AF: 40 males, 66 ± 16 years; 23 with persistent AF: 14 males, 69 ± 11 years) and 18 controls were included. Among paroxysmal patients: i) medical therapy alone was performed in 45 cases and ablation procedure in 23. AF was spontaneously resolutive in 6 cases; ii) 23 underwent ablation procedure and blood was collected simultaneously in a brachial vein and in the left atrium; 17 were spontaneously in sinus rhythm while 6 were in sinus rhythm after direct current cardioversion. Among persistent patients: i) in 17 patients, blood samples were collected in a brachial vein before and after direct current cardioversion; ii) in 6 patients, blood samples were collected simultaneously in a brachial vein and in left atrium before and after cardioversion during ablation procedure. CV-APL was higher in patients with persistent AF vs patients with paroxysmal AF (median [range]: 0.9[0.6-1.1] vs 0.7[0.4-1.1] μM; p < 0.001). In patients with paroxysmal AF, LA-APL increased during the AF episode (0.95[0.85-1.4] vs 2.7[1.5-7] μM; p = 0.03) and normalized in sinus rhythm after DCCV. In patients with persistent AF, LA-APL was higher than CV-APL (1.2[0.7-1.8] vs 0.9[0.6-1.1] μM; p < 0.001), and both normalized in sinus rhythm (CV-APL: 0.8[0.6-1.1] vs 0.75[0.4-1] μM; p = 0.03), (LA-APL: 1.95[1.3-3] vs 1[0.5-1.15] μM; p = 0.03). The occurrence of AF is associated with a strong increase of APL in the atrium. The cause of this increase needs further investigations.

Entities:  

Keywords:  Ablation procedure; Adenosine; Atrial fibrillation

Mesh:

Substances:

Year:  2018        PMID: 30535950      PMCID: PMC6439011          DOI: 10.1007/s11302-018-9636-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  8 in total

1.  Adaptative mechanism of the equilibrative nucleoside transporter 1 (ENT-1) and blood adenosine levels in elite freedivers.

Authors:  M Marlinge; D Vairo; R Guieu; F Joulia; A Bertaud; C Vernet; M Chefrour; L Bruzzese; M C Chaptal; G Mottola; A Boussuges; J J Risso; M Blot-Chabaud; M Coulange
Journal:  Eur J Appl Physiol       Date:  2020-10-14       Impact factor: 3.078

Review 2.  Adenosine and the Cardiovascular System: The Good and the Bad.

Authors:  Régis Guieu; Jean-Claude Deharo; Baptiste Maille; Lia Crotti; Ermino Torresani; Michele Brignole; Gianfranco Parati
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

3.  Impaired neuronal sodium channels cause intranodal conduction failure and reentrant arrhythmias in human sinoatrial node.

Authors:  Ning Li; Anuradha Kalyanasundaram; Brian J Hansen; Esthela J Artiga; Roshan Sharma; Suhaib H Abudulwahed; Katelynn M Helfrich; Galina Rozenberg; Pei-Jung Wu; Stanislav Zakharkin; Sandor Gyorke; Paul Ml Janssen; Bryan A Whitson; Nahush A Mokadam; Brandon J Biesiadecki; Federica Accornero; John D Hummel; Peter J Mohler; Halina Dobrzynski; Jichao Zhao; Vadim V Fedorov
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

4.  The Prevalence of Metabolic Syndrome According to Grip Strength in Teenagers.

Authors:  Duk Han Ko; Young Kyun Kim
Journal:  Children (Basel)       Date:  2021-02-04

5.  Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Authors:  Mindi Zhao; Xiaoyan Liu; Xiaoxiao Bu; Yao Li; Meng Wang; Bo Zhang; Wei Sun; Chuanbao Li
Journal:  PeerJ       Date:  2022-08-09       Impact factor: 3.061

6.  Adenosine A2A Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients.

Authors:  Héctor Godoy-Marín; Romain Duroux; Kenneth A Jacobson; Concepció Soler; Hildegard Colino-Lage; Veronica Jiménez-Sábado; José Montiel; Leif Hove-Madsen; Francisco Ciruela
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923

7.  Hyperoxia During Exercise: Impact on Adenosine Plasma Levels and Hemodynamic Data.

Authors:  Alain Boussuges; Sarah Rives; Marion Marlinge; Guillaume Chaumet; Nicolas Vallée; Régis Guieu; Olivier Gavarry
Journal:  Front Physiol       Date:  2020-02-11       Impact factor: 4.566

Review 8.  Pharmacologic Approach to Sinoatrial Node Dysfunction.

Authors:  Pietro Mesirca; Vadim V Fedorov; Thomas J Hund; Angelo G Torrente; Isabelle Bidaud; Peter J Mohler; Matteo E Mangoni
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-05       Impact factor: 13.820

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.